Phenycure Eye Drops contain Phenylephrine (2.5% w/v), a clinically proven mydriatic agent used for pupil dilation in diagnostic eye exams, surgical procedures, and therapeutic ophthalmic care. Its formulation ensures rapid, safe, and controlled mydriasis for accurate evaluation.
Phenylephrine works by stimulating the iris dilator muscles, providing precise pupil enlargement needed for retinal examination, intraocular surgery, and other ophthalmic procedures. This ensures clinical efficiency and patient comfort.
The 2.5% strength allows effective dilation with minimal systemic absorption, making it suitable for repeated ophthalmic use under supervision.
From a business perspective, Phenycure Eye Drops are part of the high-demand mydriatic segment, offering steady prescription flow, repeat orders, and reliable profitability for PCD pharma franchise partners. Its trusted efficacy and prescriber confidence make it a strong portfolio addition for ophthalmic care distributors.